Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

7.95
-0.0050-0.06%
Volume:488.90K
Turnover:3.87M
Market Cap:550.06M
PE:-10.98
High:7.98
Open:7.91
Low:7.88
Close:7.95
Loading ...
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Correspondence

Form CORRESP - Correspondence
May 12, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 12, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans